Stock KYMR KYMERA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Kymera Therapeutics, Inc.

Equities

KYMR

US5015751044

Real-time Estimate Cboe BZX
Other stock markets
 12:14:25 2024-05-21 pm EDT 		5-day change 1st Jan Change
35.98 USD -0.08% Intraday chart for Kymera Therapeutics, Inc. +3.32% +42.40%
May. 16 Transcript : Kymera Therapeutics, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 04:20 PM
May. 14 Kymera Therapeutics to Present New Clinical Data from the Ongoing Phase 1 Trial of Stat3 Degrader KT-333 At EHA Annual Meeting CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
KYMERA THERAPEUTICS, INC. Stock Kymera Therapeutics, Inc.
 2.21B -
MODERNA, INC. Stock Moderna, Inc.
 54.04B -
LONZA GROUP AG Stock Lonza Group AG
 41.96B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 41.92B
CELLTRION, INC. Stock Celltrion, Inc.
 28.35B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 26.35B
  1. Stock Market
  2. Equities
  3. KYMR Stock
  4. Charts Kymera Therapeutics, Inc.
  5. Sector Chart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW